Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274M
-
Number of holders
-
338
-
Total 13F shares, excl. options
-
262M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$5.92B
-
Value change
-
+$51.1M
-
Put/Call ratio
-
0.86
-
Number of buys
-
157
-
Number of sells
-
-160
-
Price
-
$22.59
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q1 2021
411 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q1 2021.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 338 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 262M shares
of 274M outstanding shares and own 95.68% of the company stock.
Largest 10 shareholders include BlackRock Inc. (32.1M shares), VANGUARD GROUP INC (29.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (20.7M shares), RENAISSANCE TECHNOLOGIES LLC (18.6M shares), FMR LLC (15.2M shares), JPMORGAN CHASE & CO (11.4M shares), Meditor Group Ltd (11.3M shares), Farallon Capital Management, L.L.C. (10.8M shares), STATE STREET CORP (9.24M shares), and PICTET ASSET MANAGEMENT LTD (6.06M shares).
This table shows the top 338 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.